Hematology NewsEuropean Commission expands denosumab indicationApril 4, 2018Multiple MyelomaLeukemia, Myelodysplasia, Transplantation
Hematology TimesAgent exhibits activity in leukemias, MDSApril 4, 2018AnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic SyndromeCML
Hematology TimesFDA approves blinatumomab to treat MRD+ BCP-ALLApril 3, 2018Leukemia, Myelodysplasia, TransplantationPharmacyALL
Hematology TimesDrug receives orphan designation for AMLApril 3, 2018Leukemia, Myelodysplasia, TransplantationPharmacyAML
Hematology NewsMRD may indicate relapse risk in AMLApril 2, 2018AMLLeukemia, Myelodysplasia, Transplantation
Hematology TimesDisease, genetics contribute to neurocognitive decline in ALLMarch 30, 2018Leukemia, Myelodysplasia, TransplantationPediatricsALL
Hematology NewsFDA expands indication for blinatumomab in treating ALLMarch 29, 2018ALLLeukemia, Myelodysplasia, Transplantation
Hematology TimesUCART19 can bridge to transplant in adultsMarch 29, 2018Leukemia, Myelodysplasia, TransplantationTransplantationALL
Hematology TimesCHMP supports expanded approval for fosaprepitantMarch 29, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPediatricsRelated Issues
Hematology TimesPhase 1 results with UCART19 in kidsMarch 28, 2018Leukemia, Myelodysplasia, TransplantationPediatricsTransplantationALL
Hematology TimesICER assesses value of CAR T-cell therapiesMarch 27, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersALLNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesLeukemia research pioneer dies at 92March 27, 2018Leukemia, Myelodysplasia, TransplantationAMLALL
Hematology NewsFDA approves nilotinib for children with CMLMarch 23, 2018CMLLeukemia, Myelodysplasia, Transplantation
Hematology TimesFDA approves nilotinib for kids with CMLMarch 23, 2018Leukemia, Myelodysplasia, TransplantationPediatricsPharmacyCML
Hematology TimesHealth Canada approves SC rituximab for CLLMarch 23, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyAggressive Lymphomas
